Sunday, July 12

Sunday, July 12, 2026

Everything we published on this day.

4 stories

BNTC · long

Benitec Biopharma INC

Benitec Biopharma's BB-301 gene therapy is in a Phase 1b/2a trial for an ultra-rare muscular dystrophy.